This document provides guidance on antenatal care. It discusses the importance of preconception care, screening and risk assessment during pregnancy, and the essential components of antenatal visits. The goals of antenatal care are to ensure the best outcomes for women and babies by screening for problems, assessing risk, treating issues, providing medications and information. Key aspects covered include taking a medical history, conducting physical exams, estimating gestation, performing essential screening tests, discussing medications and vaccines, creating a management plan, and covering topics for subsequent routine prenatal visits.
Preterm labor is the labor that starts before the 37th completed week. In this presentation, we will discover causes, pathogenesis, diagnosis, clinical features, and management principles for preterm labor along with the most recent evidence.
Preterm labor is the labor that starts before the 37th completed week. In this presentation, we will discover causes, pathogenesis, diagnosis, clinical features, and management principles for preterm labor along with the most recent evidence.
CTG Interpretation, evidence based approach
Cardiotocography (CTG) or electronic fetal monitoring (EFM) is the most widely used technique for assessing fetal wellbeing in labour in the developed world. The primary purpose of fetal surveillance by CTG is to prevent adverse fetal outcomes. Continuous electronic foetal monitoring is recommended to assure fetal wellbeing in labour in high risk pregnant women. Understanding pathophysiology of fetal heart rate variation will help appropriate interpretation of the CTG.
Features & classification of CTG according to RCOG will be demonstrated in this presentation with sufficient trace demonstration.
Infertility is typically defined as the inability to achieve pregnancy after
one year of unprotected intercourse. If you have been trying to conceive
for a year or more, you should consider an infertility evaluation.
Labour induction
Induction of labour
Guidelines on induction of labour
Guidelines on labour induction
induction of labour is not risk free
prostaglandins for induction of labour
Bishop score
Cervical ripening techniques
mechanical and pharmacological induction of labour
Post dates induction
options for cervical ripening
oral vs. vaginal misoprostol
advantages diadvantages and techniques for induction of labour
gynecology & obstetrics
Labour induction methods
review of guidelines for labour induction
CTG Interpretation, evidence based approach
Cardiotocography (CTG) or electronic fetal monitoring (EFM) is the most widely used technique for assessing fetal wellbeing in labour in the developed world. The primary purpose of fetal surveillance by CTG is to prevent adverse fetal outcomes. Continuous electronic foetal monitoring is recommended to assure fetal wellbeing in labour in high risk pregnant women. Understanding pathophysiology of fetal heart rate variation will help appropriate interpretation of the CTG.
Features & classification of CTG according to RCOG will be demonstrated in this presentation with sufficient trace demonstration.
Infertility is typically defined as the inability to achieve pregnancy after
one year of unprotected intercourse. If you have been trying to conceive
for a year or more, you should consider an infertility evaluation.
Labour induction
Induction of labour
Guidelines on induction of labour
Guidelines on labour induction
induction of labour is not risk free
prostaglandins for induction of labour
Bishop score
Cervical ripening techniques
mechanical and pharmacological induction of labour
Post dates induction
options for cervical ripening
oral vs. vaginal misoprostol
advantages diadvantages and techniques for induction of labour
gynecology & obstetrics
Labour induction methods
review of guidelines for labour induction
E. Atypical HUS (aHUS)
1. Epidemiology. aHUS is much less common than STEC-HUS.
2. Etiology
a. Drugs (e.g., oral contraceptives, cyclosporine, tacrolimus) or pregnancy may cause
aHUS.
b. Inherited aHUS occurs with both autosomal dominant and autosomal recessive
inheritance patterns, although not all patients have identifiable mutations. These
genetic mutations cause chronic, excessive activation of complement, which also
leads to platelet activation, endothelial cell damage, and systemic thrombotic
microangiopathy.
3. Clinical features. Clinical findings are similar to those of STEC-HUS. Diarrhea may also
be present, and severe proteinuria and hypertension are more consistently found. The
clinical course is generally more severe with multiorgan damage.
4. Management. Treatment is supportive. Inciting medications, if any, must be stopped
immediately.
5. Prognosis. Some patients have a chronic relapsing course (recurrent HUS). All patients
with aHUS have a higher risk of progression to ESRD than patients with STEC-HUS.
To understand the principles of taking an obstetric history.
To understand the key components of an obstetric examination
The patient is normally a healthy woman undergoing a normal life event.
The type of questions asked during the history change with gestation, as does the purpose and nature of the examination.
The history will often cover physiology, pathology and psychology
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Intro
• Antenatal care attempts to ensure, by antenatal preparation, the best
possible pregnancy outcome for women and their babies.
• This can be achieved by:
• Screening for pregnancy problems
• Assessment of pregnancy risk
• Treatment of problems that may arise during the antenatal period
• Giving medications that may improve pregnancy outcome
• Provision of information to pregnant women
3. PRECONCEPTION CARE
• This is the optimisation of a woman’s health or knowledge before she
plans or conceives a pregnancy.
• All health workers who care for women in the reproductive age group
need to consider the possible effect of pregnancy on women.
• If pregnancy is not desired, appropriate counselling and advice on
contraception may be offered.
4. PRECONCEPTION CARE
The following considerations will assist in preparing:
• The presence of any medical conditions controlled or uncontrolled
• If HIV positive consider viral load values
• Medication or radiation needed
• Family history and genetic risks,
• Possible occupational and environmental exposures
• Use of tobacco, alcohol, cocaine and other recreational drugs
• Social, economic and family issues (include paternal involvement)
• The past obstetric history, nutritional issues, e.g. under weight or obesity
• Immunity to rubella by previous exposure or vaccination
• Mental health issues
• The value of peri-conceptual folate
5. RISK FOR GENETIC DISEASE AND
TERATOGENICITY
Red alert for health worker if following exposures have occurred:
• Mother over age 35 years
• Alcohol and recreational drug, traditional substances and smoking
• Parents closely related
• Family history of genetic disorders
• Medical conditions in pregnancy (e.g. diabetes, epilepsy) - especially if
poorly controlled
• Teratogenic medications during pregnancy
• Maternal infections, e.g. rubella and syphilis, during pregnancy
6. THE MATERNITY CASE RECORD
• All pregnant women that present to a healthcare facility, should have,
or should receive, the latest version of the Maternity Case Record
(MCR)
• This standardised national document is the principal record of the
pregnancy, and it must be completed at each antenatal clinic visit and
retained by the mother until delivery, after which it will be kept at the
place of confinement or final referral.
• Only a record of attendance, with results of special investigations,
needs to be kept at the antenatal clinic for audit and backup
purposes.
• The MCR serves as official communication tool between the different
levels of care and health facilities
7. THE FIRST ANTENATAL VISIT
• A woman should visit her healthcare provider as soon as she suspects
pregnancy, even as early as the first missed menstrual period.
• Urine pregnancy tests must be available at all healthcare facilities.
• Women who present to primary care clinics and are found to be
pregnant must be issued with a MCR and receive the first visit
• Those who request termination of pregnancy should be appropriately
counselled and referred
8. HISTORY TAKING
Take a full and relevant history including:
• Current pregnancy
• Previous pregnancies, any complications and outcomes
• Medical conditions and previous operations
• Familial and genetic disorders
• Allergies
• Use of medications
• Use of alcohol, tobacco and other substances
• Family and social circumstances
• Experience of violence
9. PHYSICAL EXAMINATION
• Ask permission to do a physical examination. Ensure privacy.
• Do a general examination including weight, height, heart rate, colour
of mucous membranes, blood pressure, a check for oedema, and
palpation for lymph nodes.
• Do a systemic examination including teeth and gums, breasts, thyroid,
and heart and lungs.
• Examine the pregnancy including inspection and palpation of the
pregnant uterus; with measurement of the symphysis-fundal height
(SFH) in centimetres
10. MID-UPPER ARM CIRCUMFERENCE
• The MUAC gives useful information on nutritional status and
pregnancy risk and is easily done
• MUAC is advantageous over body mass index because height does
not need to be measured, accurate scales are not required, the
woman does not have to stand up straight, no calculations need be
done, and MUAC, unlike weight, does not normally increase
significantly during pregnancy.
• A MUAC ≥33 cm: suggests obesity
• A MUAC <23 cm: suggests malnutrition or a chronic wasting illness
11. ESTIMATION OF GESTATIONAL AGE
• The first estimation of gestational age, should be used for the
remainder of the pregnancy and must not be changed unless
important new information becomes available.
• Last menstrual period: This is valid if the woman is sure of her dates,
and where SFH measurement is compatible with the given dates
• Symphysis-fundal height (SFH): This is used for estimation of
gestational age after 24 weeks if the dates from the last menstrual
period are unknown or wrong, in the presence of a normal singleton
pregnancy
• Ultrasound: Requested for women who are unsure of dates with SFH
measurement less than 24 cm.
12. ESSENTIAL SCREENING
• HIV serology, using rapid test kits (routine counselling and voluntary
testing).
• TB screening at each antenatal visit.
• Syphilis serology: Rapid tests are preferable, as results are immediately
available.
• Rhesus (D) blood group, using a rapid test.
• Haemoglobin (Hb) level, using a portable haemoglobinometer or copper
sulphate screening method. Repeat Hb measurements at 30 and 38 weeks
of gestational age.
• Urine dipstick testing for protein and glucose at each antenatal visit.
• Mental health screen
13. SCREENING TESTS THAT ARE NOT OFFERED
ROUTINELY
Indicated in some circumstances:
• ABO blood group
• Screening for Down’s syndrome
• Rubella serology
• Blood glucose screening
• Cervical (Papanicolaou) smear
• Urine culture
• Ultrasound scan
14. MEDICATIONS AND VACCINES
• Ferrous sulphate tablets 200 mg daily, to prevent anaemia
• Calcium tablets 1000 mg daily, to prevent complications of pre-
eclampsia (e.g. calcium carbonate (168 mg) two tablets orally, three
times daily with food. This is best taken four hours before or after iron
supplements.
• Folic acid tablets five milligram daily
• Covid-19 vaccine
• Influenza vaccine
• Tetanus toxoid (TT) immunisation, to prevent neonatal tetanus
15. MANAGEMENT PLAN
The final assessment should include:
• Check-list for risk factors (use the ‘BANC Plus Clinic Checklist)
• A best estimate of gestational age
• A plan for management or appropriate referral for any problems
16. INFORMATION FOR PREGNANT WOMEN
• Five danger signs and symptoms of pregnancy
• Self-care in pregnancy
• A delivery plan
• Newborn and infant care
17. SUBSEQUENT ANTENATAL VISITS
• A Basic Antenatal Care plus schedule of 7 follow-up visits (8 visits in
total) is provided for women without any risk factors.
• Following the early booking visit (preferably <12 weeks), return visits
should be scheduled for 20, 26, 30, 34, 36,38 and 40 weeks, and 41
weeks if still pregnant by then
• This is not applicable for women with risk factors or who develop a
risk factor during pregnancy.
18. CONTENT OF SUBSEQUENT ANTENATAL
VISITS
• Ask about general well-being, fetal movements, danger symptoms and any
problems.
• Check the blood pressure, heart rate and colour of the mucous
membranes.
• Measure the symphysis-fundal height (SFH) in cm. Plot the SFH
• Palpate the presenting part from 34 weeks
• Test the urine for protein and glucose at each visit.
• Repeat syphilis test at 34 weeks for all women who tested negative at
initial testing.
• Repeat HIV test every routine BANC+ visit for all women who tested
negative at initial testing.
• Repeat blood tests: Hb at 30 and 38 weeks
19. CONTENT OF SUBSEQUENT ANTENATAL
VISITS
• Repeat information for danger signs of pregnancy, and review delivery
and transport plans, as well as feeding and contraception choices.
• Repeat mental health screen, in second and third trimesters
• At 38 weeks, remind the woman to bring her MCR with her when she
presents to the clinic or hospital in labour.
• At 36/38 weeks, prepare person for what to bring for labour and
delivery (KMC wrap, woolen hat and booties)
• Link and arrange Ward Based Community Outreach Teams home visits
Physical and psychological preparation for childbirth and parenthood
five milligrams daily three months prior to conception continuing into the pregnancy)
How to measure the MUAC:
● measure the MUAC just before or just after checking the blood pressure
● use a soft tape-measure, as for symphysis-fundal height
● the arm should hang freely (elbow extended)
● measure the MUAC at any gestation, or during or after labour
● measure the arm circumference in either the right or left arm, midway between the tip of the shoulder (acromion) and the tip of the elbow (olecranon). Record the measurement to the nearest one millimetre
● record the MUAC in the MCR on the antenatal card
Fetal measurements by ultrasound give reasonably accurate gestational age estimates before 24 weeks of gestation, Ultrasound after 24 weeks is less reliable, but in obese patients, it can still be used up to 28 weeks.
●Mental health screen. This brief screening tool is in the MCR. Screen if there is a referral pathway (e.g. to mental health nurse, social worker, NGO, medical officer etc). First, build empathic relationship with the person otherwise screening results will be invalid. Refer for care if concerned, even if screen negative. Consider repeat screening in each trimester and postnatal. Consider referral of all teens, women experiencing violence, even if screen negative. See Chapter X on mental health including how to screen and refer.
● tetanus toxoid (TT) immunisation, to prevent neonatal tetanus:
o first pregnancy: TT1 at first antenatal visit, TT2 four weeks later and TT3 six months later
o later pregnancies: Two TT boosters, one in each pregnancy at the first visit, for the next two subsequent pregnancies, at least one year apart
o a total of five properly spaced doses of TT provide life-long protection against tetanus.
o If in a subsequent pregnancy, there is no record of previous immunisation, treat as for a first pregnancy